Low-strength evidence for hepatocellular carcinoma screening in liver disease
1. This systematic review identified very-low strength evidence pertaining to the benefits of screening for hepatocellular carcinoma (HCC) among patients ...
1. This systematic review identified very-low strength evidence pertaining to the benefits of screening for hepatocellular carcinoma (HCC) among patients ...
1. Transarterial chemoembolization (TACE) was shown to have survival and treatment response rates comparable to both hepatic resection (HR) and ...
Image: PD 1. In patients with hepatocellular carcinoma who underwent liver transplantation, response to transarterial chemoembolization and radiologic size of ...
Image: PD 1. The risk of hepatocellular carcinoma recurrence increased with high levels of hepatitis B surface antigen (HBsAg), specifically ...
Image: PD 1. Patients at high risk for hepatocellular carcinoma who underwent biannual screening with serum AFP levels and liver ...
Image: PD 1. Liver failure was more frequent in post-hepatectomy patients with HBV reactivation, resulting in shorter 3-year disease-free survival ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.